Abstract: Provided herein are methods for treating chronic pain by administering low doses of buprenorphine twice daily (or once daily) via a transmucosal drug delivery device. The methods and devices efficiently treat chronic pain without significant side effects.
Type:
Application
Filed:
December 21, 2012
Publication date:
February 9, 2017
Applicant:
BIODELIVERY SCIENCES INTERNTIONAL, INC.
Abstract: Provided herein are methods for treating chronic pain by administering low doses of buprenorphine twice daily (or once daily) via a transmucosal drug delivery device. The methods and devices efficiently treat chronic pain without significant side effects.
Type:
Application
Filed:
December 21, 2012
Publication date:
June 26, 2014
Applicant:
BIODELIVERY SCIENCES INTERNTIONAL, INC.
Abstract: The present invention relates to a pharmaceutical delivery device for application of a pharmaceutical to mucosal surfaces. The device comprises an adhesive layer and a non-adhesive backing layer, and the pharmaceutical may be provided in either or both layers. Upon application, the device adheres to the mucosal surface, providing localized drug delivery and protection to the treatment site. The kinetics of erodability are easily adjusted by varying the number of layers and/or the components.
Type:
Application
Filed:
May 3, 2013
Publication date:
December 26, 2013
Applicant:
BIODELIVERY SCIENCES INTERNTIONAL, INC.